Actively Recruiting
Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses
Led by University of Michigan · Updated on 2025-08-26
3
Participants Needed
1
Research Sites
137 weeks
Total Duration
On this page
Sponsors
U
University of Michigan
Lead Sponsor
U
United States Department of Defense
Collaborating Sponsor
AI-Summary
What this Trial Is About
Individuals with an above-knee lower limb amputation are known to walk more slowly, expend more energy, have a greater risk of falling, and have reduced quality of life compared to individuals without amputation and those with below knee amputation. One of the driving factors behind these deficits is the lack of active function provided by above-knee prostheses with prosthetic knees and ankles. While many prosthetic devices have been developed for functional restoration after major lower extremity amputation, there remains no stable interface to facilitate reliable, long-term volitional control of an advanced robotic limb capable moving multiple joints. Moreover, there is no existing interface that provides useful sensory feedback that in turn enhances the functional capabilities of the prosthesis. To achieve both greater signal specificity and long-term signal stability, we have developed a biologic interface known as the Regenerative Peripheral Nerve Interface (RPNI). An RPNI consists of a peripheral nerve that is implanted into a free muscle graft that would otherwise go unused in the residual limb. As the nerve grows, it reinnervates the free muscle graft which undergoes a predictable sequence of revascularization and regeneration. The main questions it aims to answer are: 1. Can the amplitude, movement specificity and stability of sciatic nerve RPNI electromyography (EMG) signals be detected up to one year post RPNI surgery? 2. Do RPNIs contain information to enable control of a physical motorized prosthetic leg with multiple degrees of freedom? 3. Does stimulation of sciatic nerve RPNIs provides meaningful sensory feedback? Consenting participants with unilateral transfemoral amputation (TFA) will: 1. Undergo RPNI surgery and electrode implantation in the residual limb. 2. Attend regular follow-up visits following surgery to assess the health and signal strength of the RPNIs and their ability to use a prescribed prosthesis between 3- and 12-months following implantation. 3. Undergo explantation of electrodes following the conclusion of data collection.
CONDITIONS
Official Title
Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Unilateral leg amputation above the knee at least 6 months before enrollment
- Low surgical risk classified as American Society of Anesthesiologists Class I or II
- Residual limb with enough soft tissue quality to support RPNI surgery (no severe crushing or scarring injuries)
- Amputee Mobility Predictor with prosthesis (AMPPRO) score of 37 or higher
- Ability to use a motorized prosthetic leg without shoe lifts or extenders on the other leg
You will not qualify if you...
- Severe pain syndromes such as complex regional pain syndrome or severe phantom pain
- Untreated mental health disorders without approval from a mental health professional
- Medical conditions posing high surgical risk like recent heart attack, stroke, blood clots, uncontrolled diabetes, or end-stage kidney disease
- Tobacco use within one month before enrollment or planned use during the study
- Pregnancy
- Presence of other implanted electronic devices like pacemakers or neurostimulators
- Severe peripheral vascular disease, venous hypertension, or severe lymphedema in the affected limb
- Uncontrolled autoimmune conditions
- Significant injury to the opposite limb
- Severe uncorrected vision problems
- Impaired mental capacity affecting communication or requiring a legal representative
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
D
Deanna Gates, PhD
CONTACT
J
Jennifer B Hamill, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here